Active ingredient
- metaraminol tartrate
Legal Category
POM: Prescription only medicine
POM: Prescription only medicine
The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine. It is written for patients and gives information about taking or using a medicine. It is possible that the leaflet in your medicine pack may differ from this version because it may have been updated since your medicine was packaged.
Below is a text only representation of the Patient Information Leaflet. The original leaflet can be viewed using the link above.
The text only version may be available in large print, Braille or audio CD. For further information call emc accessibility on 0800 198 5000. The product code(s) for this leaflet is: PL13079/0012 .
Metaraminol 0.5mg/mL Solution for Injection
Package Leaflet: Information for the user
Metaraminol 0.5mg/mL Solution for Injection
Metaraminol Tartrate
Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
What is in this leaflet:
1. What Metaraminol 0.5mg/mL Solution for Injection is and what it is used for
2. What you need to know before you use Metaraminol 0.5mg/mL Solution for Injection
3. How to use Metaraminol 0.5mg/mL Solution for Injection
4. Possible Side Effects
5. How to store Metaraminol 0.5mg/mL Solution for Injection
6. Contents of the pack and other information
1. What Metaraminol 0.5mg/mL Solution for Injection is and what it is used for
Metaraminol 0.5mg/mL Solution for Injection contains the active substance Metaraminol Tartrate and belongs to a group of medicines called vasopressors which work by narrowing the blood vessels causing blood pressure to rise.
It is used to:
2. What you need to know before you use Metaraminol 0.5mg/mL Solution for Injection
You will be given this medicine in hospital by a doctor or nurse.
Do not use this medicine:
Warnings and Precautions
Talk to your doctor, nurse or pharmacist before using Metaraminol 0.5mg/mL Solution for Injection if you have:
Children
This medicine is not recommended for use in children below the age of 12 years.
Other medicines and Metaraminol 0.5mg/mL Solution for Injection
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. It is especially important if you are taking:
Pregnancy, breast-feeding and fertility
The effects of this medicine on the unborn baby is unknown. It is not known whether this medicine is present in breast milk. You will only be given this medicine if your doctor sees the clinical need to do so in an emergency situation.
Metaraminol 0.5mg/mL Solution for Injection contains sodium metabisulfite and sodium chloride
This medicine contains
3. How to use Metaraminol 0.5mg/mL Solution for Injection
A nurse or doctor will give you this medicine.
The recommended dose is:
In the case of an emergency, this medicine is given by direct injection into a vein, which may be followed by an infusion into a vein. The dose will be adjusted by your doctor, but the usual dose is between 0.5 – 5mg (1 – 10mL) injected into the vein, followed by an infusion of 15 – 100mg (30 – 200mL of metaraminol 0.5mg/mL solution for injection).
Metaraminol 0.5mg/mL Solution for Injection is already diluted and ready to use. It should be used without prior dilution.
If you are given more Metaraminol 0.5mg/mL Solution for Injection than you should
It is unlikely that you will receive too much because this medicine will be given to you in hospital. You will be carefully monitored by your doctor for symptoms or severely high blood pressure (see symptoms in Section 4 Possible Side Effects).
4. Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Tell your doctor immediately if you experience:
The following symptoms may be due to severely high blood pressure. Tell your doctor immediately if you experience:
Tell your doctor as soon as possible if you experience:
Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App store. By reporting side effects, you can help provide more information on the safety of this medicine.
5. How to store Metaraminol 0.5mg/mL Solution for Injection
The expiry date refers to the last day of the month. Before use, the doctor or nurse will check the medicine has not passed this date and that the medicine does not show any sign of deterioration.
6. Contents of the pack and other information
What Metaraminol 0.5mg/mL Solution for Injection contains
What Metaraminol 0.5mg/mL Solution for Injection looks like and contents of the pack:
This medicine is a clear, colourless solution in a 5 mL or 10 mL glass ampoule. This medicine is packed into cartons containing 10 ampoules.
Marketing Authorisation Holder and Manufacturer:
Medical enquiries:
This leaflet was last revised in: April 2019
PL 13079/0012
Wilkins Drive, Paignton, TQ4 7FG
+44 (0)1803 660000
+44 (0)7824 889143
+44 (0)1803 664707
+44 (0)1803 664707
+44 (0)1803 664354
+44 (0)1803 664 354